# Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

> **NCT02469207** · — · UNKNOWN · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 50 (estimated)

## Conditions studied

- Graft Rejection
- Transplantation
- Diabetes Mellitus

## Interventions

- **OTHER:** Removal of tissue post-mortem

## Key facts

- **NCT ID:** NCT02469207
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469207, "Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02469207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*